PSP Research LLC

Q2 2026 13F-HR Holdings

Location
Las Vegas, NV
Holdings as of
6/30/2026
Date filed
7/9/2026
Form type
13F-HR
Num holdings
75
Total value ($000)
$187,882
Net value change ($000)
+46,552 (32.9%)
New positions
11
Sold out positions
15
Turnover %
6.7%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
XBI 53,813 147.9%
Ascendis Pharma AS 400 NEW
LQDA 399 NEW
KRYS 257 NEW
AVBP 245 NEW
JAZZ 234 NEW
RVMD 225 NEW
RYTM 222 NEW
DNLI 218 NEW
ARWR 212 NEW
Top Reduces (Value $000, Stocks/ETFs)
SERA -4,865 -100.0%
TYRA -613 -100.0%
ASND -572 -100.0%
CYTK -547 -100.0%
AGIO -507 -100.0%
PRAX -483 -100.0%
INBX -466 -100.0%
ERAS -280 -100.0%
AXSM -236 -49.1%
CELC -228 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type